Paul Schimmel

Paul Schimmel

Gründer bei
Reactive Biosciences, Inc.

Vermögen: 1 Mio $ am 30.06.2026

85 Jahre
Health Technology
Commercial Services
Finance

Profil

Paul R.
Schimmel
was the founder of Reactive Biosciences, Inc. (founded 2021), Alkermes, Inc. (founded 1987), Metabolon, Inc. (founded 2000), Abide Therapeutics, Inc. (founded 2011; Director), aTyr Pharma, Inc. (founded 2005; Independent Director), Repligen Corp.
(founded 1981; Co-Chairman), Alnylam Pharmaceuticals, Inc. (founded 2002; Independent Director), Momenta Pharmaceuticals, Inc. (founded 2001; Director), and Sirtris Pharmaceuticals, Inc. (founded 2004; Director).
Dr. Schimmel is also the founder of Cubist Pharmaceuticals LLC..
Current positions include Director at KinDex Pharmaceuticals, Inc. and Tevard Biosciences, Inc., Professor at The Scripps Research Institute (since 1997) and Skaggs Institute For Chemical Biology, Member of the National Academy of Sciences, National Academy of Medicine (United States), National Academy of Inventors, American Academy of Arts & Sciences, American Philosophical Society, and National Academy of Medicine, Advisor at Longwood Fund Management LLC, and Venture Partner at CHP Management, Inc. Former positions include Chairman of the Biological Chemistry Division at the American Chemical Society, Director at Momenta, Inc., Independent Director at Tocagen, Inc. (2015–2020), Director at Avicena Group, Inc., Vividion Therapeutics, Inc., and Alkermes Plc, Professor at Massachusetts Institute of Technology, and Member of the Scientific Advisory Board at Illumina, Inc. Education includes a doctorate from Cornell University, a doctorate from Massachusetts Institute of Technology (1966), and undergraduate studies at Ohio Wesleyan University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
27.05.2026 2’201’056 ( 2.24% ) 1 Mio $ 30.06.2026

Aktive Positionen von Paul Schimmel

UnternehmenPositionBeginn
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Private Equity Investor -
Corporate Officer/Principal -
Corporate Officer/Principal -
Direktor/Vorstandsmitglied -
Gründer 01.01.2021
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Paul Schimmel

UnternehmenPositionEnde
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Sehen Sie sich die Erfahrung von Paul Schimmel im Detail an

Ausbildung von Paul Schimmel

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

75

Beziehungen ersten Grades

32

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Distribution Services

National Academy of Medicine

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Skaggs Institute For Chemical Biology

  1. Börse
  2. Insiders
  3. Paul Schimmel